Skip to search formSkip to main contentSkip to account menu

CDB 4124

Known as: CDB-4124, CDB4124 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

telapristone acetate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Abstract 1812: Mechanism of telapristone acetate (CDB4124) on progesterone receptor action in breast cancer cells
Progesterone is a steroid hormone that plays an important role in the breast. Progesterone exerts its action through binding to… 
2015
2015
Abstract P6-07-07: Low dose of CDB-2914 and CDB-4124 efficiently inhibit the growth of T47D spheroid induced by pre-menopausal and post-menopausal concentrations of estrogen and progesterone
Background: The anti-progestins (RU-486, CDB-2914 and CDB-4124) may have potential to prevent estrogen receptor (ER) and… 
2014
2014
Allopregnanolone's attenuation of the lordosis-inhibiting effects of restraint is blocked by the antiprogestin, CDB-4124
2013
2013
Synthesis and antiprogestational properties of novel 17-fluorinated steroids
2013
2013
An antiprogestin, CDB4124, blocks progesterone's attenuation of the negative effects of a mild stress on sexual behavior
2013
2013
Abstract P4-11-02: Mammary tumor formation induced by N-methyl-N-nitrosourea (MNU) is accelerated by natural and synthetic progesterone but suppressed by an anti-progesterone CDB4124
Background: CDB4124, anti-progesterone suppresses the development of carcinogen-induced ER+/PR+ mammary tumors in rats, and may… 
2010
2010
Nouvelle forme cristalline de l'antiprogestérone cdb-4124
L'invention concerne une nouvelle forme cristalline A de 17α-acetoxy-21-methoxy- l lβ-[4-N,N-dimethylaminophenyl]-19-norpregna-4… 
2010
2010
Abstract P4-02-07: A Progesterone Receptor Modulator, CDB-4124, Inhibits Mammary Carcinogenesis by Suppressing Cell Proliferation In Vitro and In Vivo
CDB-4124 (Proellex or Telapristone acetate) is a modulator of progesterone receptor (PR) signaling which has been employed in… 
2009
2009
Progesterone antagonists such as cdb-4124 in the treatment of endometriosis, uterine fibroids, dysmenorrhea, breast cancer etc
The present invention relates to a method of administering a composition comprising a progesterone receptor antagonist for use in… 
2008
2008
The activities of progesterone receptor isoform A and B are differentially modulated by their ligands in a gene‐selective manner
It is known that progesterone receptor (PR) isoform A (PR‐A) and isoform B (PR‐B) may mediate different effects of progesterone… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)